You just read:

Ascendis Pharma A/S to Report Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone and Host Conference Call on Thursday, July 30, 2015 at 9:00 a.m. Eastern Time

News provided by

Ascendis Pharma A/S

Jul 29, 2015, 05:00 ET